Towards rational axillary treatment in relation to neoadjuvant therapy in breast cancer

European Journal of Cancer

Volumn 45, Issue 13, 2009, Pages 2284-2292

  Straver, M E ^a   Rutgers, E J Th ^a   Russell, N S ^a   Oldenburg, H S A ^a   Rodenhuis, S ^a   Wesseling, J ^a   Vincent, A ^a   Peeters, M T F D Vrancken ^a  

^a ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

Author keywords

Breast neoplasms; Lymph node excision; Lymphatic metastasis; Neoadjuvant therapy; Sentinel lymph node biopsy

Indexed keywords

CAPECITABINE; CARBOPLATIN; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; PACLITAXEL; TRASTUZUMAB;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER SURGERY; CONTROLLED STUDY; CYTOLOGY; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MASTECTOMY; MULTIPLE CYCLE TREATMENT; PRIMARY TUMOR; PRIORITY JOURNAL; SENTINEL LYMPH NODE BIOPSY; ULTRASOUND;

ADULT; AGED; AXILLA; BREAST NEOPLASMS; FEMALE; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; PROGNOSIS; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SENTINEL LYMPH NODE BIOPSY; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 68749100792     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2009.04.029     Document Type: Article

References (29)

1. Kilbride K.E., Lee M.C., Nees A.V., et al. Axillary staging prior to neoadjuvant chemotherapy for breast cancer: predictors of recurrence. Ann Surg Oncol (2008)
2. Rouzier R., Extra J.M., Klijanienko J., et al. Incidence and prognostic significance of complete axillary downstaging after primary chemotherapy in breast cancer patients with T1 to T3 tumors and cytologically proven axillary metastatic lymph nodes. J Clin Oncol 20 (2002) 1304-1310
3. Xing Y., Foy M., Cox D.D., et al. Meta-analysis of sentinel lymph node biopsy after preoperative chemotherapy in patients with breast cancer. Brit J Surg 93 (2006) 539-546
4. Lyman G.H., Giuliano A.E., Somerfield M.R., et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 23 (2005) 7703-7720
5. Prati R., Minami C.A., Gornbein J.A., et al. Accuracy of clinical evaluation of locally advanced breast cancer in patients receiving neoadjuvant chemotherapy. Cancer (2009)
6. Hannemann J., Oosterkamp H.M., Bosch C.A., et al. Changes in gene expression associated with response to neoadjuvant chemotherapy in breast cancer. J Clin Oncol 23 (2005) 3331-3342
7. Mazouni C., Peintinger F., Wan-Kau S., et al. Residual ductal carcinoma in situ in patients with complete eradication of invasive breast cancer after neoadjuvant chemotherapy does not adversely affect patient outcome. J Clin Oncol 25 (2007) 2650-2655
8. Gil-Rendo A., Zornoza G., Garcia-Velloso M.J., et al. Fluorodeoxyglucose positron emission tomography with sentinel lymph node biopsy for evaluation of axillary involvement in breast cancer. Brit J Surg 93 (2006) 707-712
9. Hodgson N.C., and Gulenchyn K.Y. Is there a role for positron emission tomography in breast cancer staging?. J Clin Oncol 26 (2008) 712-720
10. Breslin T.M., Cohen L., Sahin A., et al. Sentinel lymph node biopsy is accurate after neoadjuvant chemotherapy for breast cancer. J Clin Oncol 18 (2000) 3480-3486
11. Gimbergues P., Abrial C., Durando X., et al. Sentinel lymph node biopsy after neoadjuvant chemotherapy is accurate in breast cancer patients with a clinically negative axillary nodal status at presentation. Ann Surg Oncol 15 (2008) 1316-1321
12. Jones J.L., Zabicki K., Christian R.L., et al. A comparison of sentinel node biopsy before and after neoadjuvant chemotherapy: timing is important. Am J Surg 190 (2005) 517-520
13. Julian T.B., Dusi D., and Wolmark N. Sentinel node biopsy after neoadjuvant chemotherapy for breast cancer. Am J Surg 184 (2002) 315-317
14. Kang S.H., Kim S.K., Kwon Y., et al. Decreased identification rate of sentinel lymph node after neoadjuvant chemotherapy. World J Surg 28 (2004) 1019-1024
15. Kinoshita T. Sentinel lymph node biopsy is feasible for breast cancer patients after neoadjuvant chemotherapy. Breast Cancer 14 (2007) 10-15
16. Lang J.E., Esserman L.J., Ewing C.A., et al. Accuracy of selective sentinel lymphadenectomy after neoadjuvant chemotherapy: effect of clinical node status at presentation. J Am Coll Surg 199 (2004) 856-862
17. Lee S., Kim E.Y., Kang S.H., et al. Sentinel node identification rate, but not accuracy, is significantly decreased after pre-operative chemotherapy in axillary node-positive breast cancer patients. Breast Cancer Res Treat 102 (2007) 283-288
18. Mamounas E.P., Brown A., Anderson S., et al. Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer: results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27. J Clin Oncol 23 (2005) 2694-2702
19. Nason K.S., Anderson B.O., Byrd D.R., et al. Increased false negative sentinel node biopsy rates after preoperative chemotherapy for invasive breast carcinoma. Cancer 89 (2000) 2187-2194
20. Newman E.A., Sabel M.S., Nees A.V., et al. Sentinel lymph node biopsy performed after neoadjuvant chemotherapy is accurate in patients with documented node-positive breast cancer at presentation. Ann Surg Oncol (2007)
21. Reitsamer R., Peintinger F., Rettenbacher L., and Prokop E. Sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapy. J Surg Oncol 84 (2003) 63-67
22. Schwartz G.F., and Meltzer A.J. Accuracy of axillary sentinel lymph node biopsy following neoadjuvant (induction) chemotherapy for carcinoma of the breast. Breast J 9 (2003) 374-379
23. Shen J., Gilcrease M.Z., Babiera G.V., et al. Feasibility and accuracy of sentinel lymph node biopsy after preoperative chemotherapy in breast cancer patients with documented axillary metastases. Cancer 109 (2007) 1255-1263
24. Shimazu K., Tamaki Y., Taguchi T., et al. Sentinel lymph node biopsy using periareolar injection of radiocolloid for patients with neoadjuvant chemotherapy-treated breast carcinoma. Cancer 100 (2004) 2555-2561
25. Stearns V., Ewing C.A., Slack R., et al. Sentinel lymphadenectomy after neoadjuvant chemotherapy for breast cancer may reliably represent the axilla except for inflammatory breast cancer. Ann Surg Oncol 9 (2002) 235-242
26. Tausch C., Konstantiniuk P., Kugler F., et al. Sentinel lymph node biopsy after preoperative chemotherapy for breast cancer: findings from the Austrian Sentinel Node Study Group. Ann Surg Oncol (2006)
27. Balch G.C., Mithani S.K., Richards K.R., Beauchamp R.D., and Kelley M.C. Lymphatic mapping and sentinel lymphadenectomy after preoperative therapy for stage II and III breast cancer. Ann Surg Oncol 10 (2003) 616-621
28. Hino M., Sano M., Sato N., and Homma K. Sentinel lymph node biopsy after neoadjuvant chemotherapy in a patient with operable breast cancer. Surg Today 38 (2008) 585-591
29. Kuerer H.M., Sahin A.A., Hunt K.K., et al. Incidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapy. Ann Surg 230 (1999) 72-78